Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions on site

Valuation: Celltrion, Inc.

Capitalization 32,832B 23.51B 21.05B 19.63B 17.7B 32.8B 2,010B 36.71B 230B 89.89B 912B 88.12B 86.28B 3,424B P/E ratio 2025 *
38x
P/E ratio 2026 * 26x
Enterprise value 34.09B 24.41M 21.85M 20.39M 18.38M 34.06M 2.09B 38.11M 238M 93.34M 947M 91.5M 89.59M 3.56B EV / Sales 2025 *
8.01x
EV / Sales 2026 * 6.38x
Free-Float
70.87%
Yield 2025 *
0.47%
Yield 2026 * 0.48%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.33%
1 week-2.53%
Current month-4.53%
1 month-3.27%
3 months-15.15%
6 months-2.24%
Current year-17.87%
More quotes
1 week 151,200
Extreme 151200
157,700
1 month 151,200
Extreme 151200
164,200
Current year 151,200
Extreme 151200
192,900
1 year 151,200
Extreme 151200
200,952.38
3 years 124,761.9
Extreme 124761.9048
229,523.81
5 years 124,761.9
Extreme 124761.9048
355,157.15
10 years 45,743.48
Extreme 45743.4823
355,157.15
More quotes
Manager TitleAgeSince
Chief Executive Officer - 2015-03-19
Director of Finance/CFO 50 -
Compliance Officer 43 -
Director TitleAgeSince
Chairman 67 -
Director/Board Member 66 2008-07-16
Director/Board Member 67 2008-07-16
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.33%-2.53%-15.56%+18.01% 23.46B
+1.27%-1.92%+8.39%+3.76% 48.25B
+1.70%-4.14%-38.22%-30.90% 24.71B
+4.62%+6.71% - - 11.34B
+1.01%-0.39%-3.67%-33.98% 11.32B
+0.74%-1.74%-58.18%-37.06% 10.46B
+5.12%+2.52%-81.29%-82.53% 9.61B
+0.04%+4.20%+30.12%+77.14% 9.51B
+0.97%+1.89%-9.25%-12.35% 9.24B
+3.12%+3.25%-22.28%+120.77% 8.79B
Average +1.89%+1.18%-21.11%+2.54% 16.67B
Weighted average by Cap. +1.61%+0.02%-15.00%-0.29%
See all sector performances

Financials

2025 *2026 *
Net sales 4,255B 3.05B 2.73B 2.54B 2.29B 4.25B 260B 4.76B 29.77B 11.65B 118B 11.42B 11.18B 444B 5,227B 3.74B 3.35B 3.13B 2.82B 5.22B 320B 5.84B 36.56B 14.31B 145B 14.03B 13.74B 545B
Net income 891B 638M 571M 533M 480M 890M 54.54B 996M 6.23B 2.44B 24.75B 2.39B 2.34B 92.93B 1,317B 943M 845M 788M 710M 1.32B 80.65B 1.47B 9.22B 3.61B 36.59B 3.54B 3.46B 137B
Net Debt 1,259B 901M 807M 753M 678M 1.26B 77.05B 1.41B 8.8B 3.45B 34.96B 3.38B 3.31B 131B 506B 362M 324M 302M 273M 505M 30.96B 565M 3.54B 1.38B 14.05B 1.36B 1.33B 52.75B
More financial data * Estimated data
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,391
More about the company
Date Price Change Volume
25-05-16 154,000.00 +0.33% 416,637
25-05-15 153,500.00 -0.52% 540,412
25-05-14 154,300.00 0.00% 529,072
25-05-13 154,300.00 +1.65% 788,857
25-05-12 151,800.00 -3.92% 1,435,072

End-of-day quote Korea S.E., May 15, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
154,000.00KRW
Average target price
225,750.00KRW
Spread / Average Target
+46.59%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW